Search Results
Oct 13, 2025, 21:30 ET GIGABYTE annonce que son supercalculateur personnel AI TOP ATOM sera disponible dans le monde entier dès le 15 octobre
l'inférence et le déploiement de grands modèles de langage (LLM), de grands modèles multimodaux (LMM) et d'applications modernes d'apprentissage automatique (ML). Des développeurs et chercheurs en IA aux étudiants et institutions, GIGABYTE AI TOP ATOM offre une solution flexible
More news about: GIGABYTE
Oct 13, 2025, 21:30 ET GIGABYTE anuncia que seu supercomputador pessoal de IA, o AI TOP ATOM, estará disponível globalmente em 15 de outubro
implantação de modelos em grandes modelos de linguagem (LLMs), grandes modelos multimodais (LMMs) e aplicativos modernos de aprendizado de máquina (ML). De desenvolvedores e pesquisadores de IA a estudantes e instituições, o GIGABYTE AI TOP ATOM oferece uma solução
More news about: GIGABYTE
Oct 13, 2025, 21:30 ET GIGABYTE anuncia que su superordenador personal de IA AI TOP ATOM estará disponible a nivel mundial el 15 de octubre
el despliegue de modelos en grandes modelos de lenguaje (LLM), grandes modelos multimodales (LMM) y aplicaciones modernas de aprendizaje automático (ML). Desde desarrolladores e investigadores de IA hasta estudiantes e instituciones, el modelo GIGABYTE AI TOP ATOM ofrece una solución
More news about: GIGABYTE
Oct 13, 2025, 21:30 ET GIGABYTE anuncia que su supercomputadora personal con IA, AI TOP ATOM, estará disponible en todo el mundo a partir del 15 de octubre
tanto en modelos de lenguaje de gran tamaño (LLM), como en modelos multimodales de gran tamaño (LMM) y aplicaciones modernas de aprendizaje automático (ML). Desde desarrolladores e investigadores de IA hasta estudiantes e instituciones, GIGABYTE AI TOP ATOM ofrece una
More news about: GIGABYTE
Oct 13, 2025, 20:00 ET Waters推出全新電荷檢測質譜技術，加速新一代生物治療藥物研發進程
分鐘內即可給出結果，即使樣本濃度低至 10¹ ⁰ vp/mL 依然表現出色。這項新技術為基因治療藥物製程開發過程中的即時表徵奠定了基礎，最終有助於提升前沿治療藥物的安全性與有效性。此外， CDMS
More news about: Waters Corporation
Oct 13, 2025, 19:50 ET Realizing the Open Data Center Ecosystem Vision
describes a 1RU tall compute tray which integrates two NVIDIA GB300 Host Processor Modules (HPM) into a form factor with peripherals that support Meta's AI/ML training and inference use cases. It also represents a milestone of a first deployment of a design that uses OCP ORv3 HPR (in-progress specification
More news about: Open Compute Project Foundation
Oct 13, 2025, 19:30 ET LEQEMBI® IQLIK™(lecanemab-irmb) Subcutaneous Autoinjector Named to TIME's "Best Inventions of 2025"
(lecanemab-irmb) is available: Intravenous infusion: 100 mg/mL Subcutaneous injection: 200 mg/mL Please see full
More news about: Eisai Inc.
Oct 13, 2025, 19:21 ET Realizing the Open Data Center Ecosystem Vision
describes a 1RU tall compute tray which integrates two NVIDIA GB300 Host Processor Modules (HPM) into a form factor with peripherals that support Meta's AI/ML training and inference use cases. It also represents a milestone of a first deployment of a design that uses OCP ORv3 HPR (in-progress specification
More news about: Open Compute Project Foundation
Oct 13, 2025, 16:27 ET EiIean Therapeutics Presents Novel Wild-Type Sparing, Reversible Pan-EGFR Inhibitor (ZE77-0273) with Broad Activity Against Resistance Mutations in EGFR-Mutant NSCLC at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
first-in-class small molecule inhibitors that target escape mutations in hematologic malignancies and solid tumors. Utilizing its proprietary hybrid AI/ML drug design platform, the company leverages proprietary partner data, advanced chem/bio tools, and deep domain expertise to identify highly valuable
More news about: Eilean Therapeutics
Oct 13, 2025, 12:38 ET Barron Venture Partners Launches Fund to Back Transformative Technologies
to every opportunity. Industries of interest include, but are not limited to, space technology, robotics, quantum computing, AI/ML, energy, semiconductors, advanced manufacturing, developer tools and infrastructure, and cryptography. About
More news about: Barron Venture Partners
Oct 13, 2025, 12:19 ET Barron Venture Partners Launches Fund to Back Transformative Technologies
to every opportunity. Industries of interest include, but are not limited to, space technology, robotics, quantum computing, AI/ML, energy, semiconductors, advanced manufacturing, developer tools and infrastructure, and cryptography. About
More news about: Barron Venture Partners
Oct 13, 2025, 10:57 ET U.S. Food and Drug Administration (FDA) Approves Updated Indication Statement for RINVOQ® (upadacitinib) for the Treatment of Inflammatory Bowel Disease
available in 15 mg, 30 mg, and 45 mg extended-release tablets. RINVOQ LQ is taken twice a day with or without food. RINVOQ LQ is available in a 1 mg/mL oral solution. RINVOQ LQ is not the same as RINVOQ tablets. Do not switch between RINVOQ LQ and RINVOQ tablets unless the change has been made by your
More news about: AbbVie
Oct 13, 2025, 10:00 ET DZYNE Expands Dronebuster® Line with New Vehicle Kits at AUSA 2025
gimbal, and select the mitigation method or automate the kill chain. This is accomplished through a simple point-and-click interface, supported by AI/ML-driven identification technology and a continuously updated drone library. Scalable and adaptable, this configuration is ideal for securing convoys,
More news about: DZYNE Technologies
Oct 13, 2025, 09:05 ET CUMBERLAND PHARMACEUTICALS' VIBATIV® ADDED TO NATIONAL GROUP PURCHASING AGREEMENT WITH PREMIER, INC.
higher cure rates for Vibativ as compared to vancomycin in HABP/VABP due to any single Gram-positive pathogen or S. aureus with vancomycin MIC ≥1 µg/mL. Additionally, there is extensive and well-documented evidence of the drug's in vitro potency and in vivo activity
More news about: Cumberland Pharmaceuticals Inc.
Oct 13, 2025, 09:00 ET Deloitte and Oracle Accelerate Agentic AI with Zora AI™
high-performance cloud infrastructure and AI offerings with Deloitte's advanced industry knowledge," said Roger Barga, senior vice president, AI and ML, Oracle. "Zora AI™ integration with the embedded AI capabilities in Oracle Fusion Applications and the AI Agent Studio for Fusion Applications will help
More news about: Deloitte LLP
Oct 13, 2025, 09:00 ET GC Biopharma Highlights IVIG Innovation and Investigator-Initiated Research as Science to Solutions Partner at the Fall 2025 CIIC Conference
About ALYGLO®ALYGLO® (immune globulin intravenous, human-stwk) is a glycine-stabilized 10% immunoglobulin G (100 mg/mL) for intravenous infusion, manufactured from pooled human plasma from US donors. The manufacturing process includes multiple steps to reduce the risk
More news about: GC Biopharma USA Inc.
Oct 13, 2025, 08:05 ET Waters Launches Charge Detection Mass Spectrometry Technology to Accelerate the Development of Next-Generation Biotherapeutics
volume than that required by current techniques, and delivering results in less than ten minutes, even at concentrations as low as 1010 vp/mL. This new capability paves the way for real-time characterization of gene therapies during process development – ultimately improving the safety and
More news about: Waters Corporation
Oct 13, 2025, 08:05 ET Waters Launches Charge Detection Mass Spectrometry Technology to Accelerate the Development of Next-Generation Biotherapeutics
volume than that required by current techniques, and delivering results in less than ten minutes, even at concentrations as low as 1010 vp/mL. This new capability paves the way for real-time characterization of gene therapies during process development – ultimately improving the safety and
More news about: Waters Corporation
Oct 13, 2025, 07:00 ET Compugen to Present Pooled Analysis of COM701 in Three Phase 1 Trials in Patients with Platinum Resistant Ovarian Cancer at ESMO 2025
Ltd. (NASDAQ: CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy company and a pioneer in predictive computational target discovery powered by AI/ML, today announced that pooled analysis of previously presented data, supporting the anti-tumor activity and safety profile of COM701 in heavily pre-treated
More news about: Compugen Ltd.
Oct 13, 2025, 06:45 ET Lilly to present new clinical data for Verzenio (abemaciclib) and multiple novel pipeline programs at the 2025 European Society for Medical Oncology (ESMO) Annual Meeting
with severe renal impairment (CLcr <30 mL/min), end stage renal disease, or in patients on dialysis is unknown. No dosage adjustments are necessary in patients with mild or moderate hepatic (Child-Pugh A or B) and/or renal impairment (CLcr ≥30-89 mL/min).
More news about: Eli Lilly and Company
Oct 13, 2025, 04:00 ET Cumulus Neuroscience Presents Data at the International Society for CNS Clinical Trials and Methodology Autumn Conference and the 38th European College of Neuropsychopharmacology Congress
clinical data repeatedly over time, across multiple behavioral and physiological domains, in the clinic and at home. Together with machine learning (ML) analytics, Cumulus simplifies and improves the robustness of CNS clinical trials, providing objective assessment of study inclusion and treatment outcomes.
More news about: Cumulus Neuroscience
Oct 10, 2025, 16:47 ET Sabrina Carpenter's Sweet Tooth Fragrances Make Their Ulta Beauty Debut
fragrance assortment at Ulta Beauty includes: Full-Size Eau de Parfum (30ml, 75ml, $35-$55)
More news about: Sweet Tooth by Sabrina Carpenter
Oct 10, 2025, 10:01 ET Data Center Accelerator Market worth $372.68 billion by 2030 - Exclusive Report by MarketsandMarkets™
hold the largest share of the data center accelerator market in 2030, driven by the rapid growth of artificial intelligence (AI) and machine learning (ML) applications across diverse industries. Inference workloads, which involve applying trained AI models to process real-time data, are critical for enabling
More news about: MarketsandMarkets
Oct 10, 2025, 01:48 ET Phi Commerce launches Phi-ter - India's first omnichannel, AI-powered real-time fraud management system
detect; it learns. It predicts potentially fraudulent activity even before the payment completes and continuously feeds that intelligence back into its AI-ML engine. Over time, it becomes sharper and more adaptive to evolving fraud behaviour," said Rajesh Londhe, Co-founder and Business Head – Payments, Phi
More news about: Phi Commerce
Oct 10, 2025, 00:30 ET Posidex Launches "PII Data Vault" at Global Fintech Fest 2025, Mumbai -- A Breakthrough in Secure Processing of PII Data using Searchable encryption
Headquartered in Hyderabad, India, Posidex Technologies is an award-winning deep-tech product company with over two decades of pioneering innovation in AI/ML-powered customer 360-degree solutions. Its platform,
More news about: Posidex Technologies